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Abstract The NCI-H292 cell, a human pulmonary mucoepi-
dermoid carcinoma cell line, is commonly used for studying
bacterial and viral infections of airway epithelial cells. Dysfunc-
tion of the cystic fibrosis transmembrane conductance regulator
(CFTR) is the main cause of fetal lung infection in cystic fibrosis
patients. In this study, we examined CFTR expression in NCI-
H292 cells to determine whether NCI-H292 cells possess
sufficient, normally functioning CFTR. The results of RT-PCR
and Northern blotting analysis indicated that the CFTR gene
expression level was much lower in NCI-H292 cells than in T84
cells. However, Western blotting analysis showed that protein
expression in NCI-H292 cells was comparable to that in T84
cells. Furthermore, whole-cell and cell-attached patch clamp
electrophysiological techniques indicated that the Cl3 current
induced by intracellular cAMP elevation in NCI-H292 cells was
comparable to that in T84 cells. These findings suggest that NCI-
H292 cells with a low level of CFTR gene expression possess
enough functional CFTR to show a physiological response.
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1. Introduction
Cystic ¢brosis (CF) is a recessive genetic disorder, which
a¡ects about 1 in 2500 Caucasian live births [1]. The morbid-
ity and death from CF result mainly from complicating pul-
monary infections and in£ammation.
The NCI-H292 cell, a human pulmonary mucoepidermoid
carcinoma cell line, is commonly used for studying bacterial
and viral infections and in£ammation in airway epithelial cells
[2^7]. For example, Pseudomonas aeruginosa lipopolysaccha-
ride profoundly upregulates transcription of the mucin gene in
NCI-H292 cells [4], and in£uenza A virus infection upregu-
lates interleukin (IL) 6, IL-8, and RANTES expression in
NCI-H292 cells [5]. The NCI-H292 cell is sensitive to the
cytotoxic activity of Bordetella bronchiseptica [6]. Haemophilus
in£uenza passes through viable layers of NCI-H292 cells by
paracytosis, which requires bacterial protein synthesis [7]. As
far as we know, this cell line is a good model for studying the
pathological changes in airway epithelial cells. It seems to us
that NCI-H292 cells readily permit the infections and in£am-
mation seen in CF patients. However, there is no information
on CFTR expression in these cells, although CFTR function
is closely tied to infectious in£ammation in airways. There-
fore, in this study, we examined CFTR gene expression, pro-
tein expression, and the functional response of the Cl3 chan-
nel.
2. Materials and methods
2.1. Cell culture
NCI-H292 (a human pulmonary mucoepidermoid carcinoma cell
line) and T84 (a colon carcinoma cell line) were purchased from the
American Type Culture Collection (Rockville, MD, USA). NCI-H292
was grown in RPMI 1640 medium supplemented with 10% fetal calf
serum, 100 U/ml penicillin, and 100 Wg/ml streptomycin, at 37‡C in a
humidi¢ed atmosphere of 95% air and 5% CO2. CFTE29o3 and
CFBE41o3 (an immortalized cystic ¢brosis tracheal and bronchial
epithelial cell line) was obtained from D.C. Gruenert. T84,
CFTE29o3 and CFBE41o3 were grown as previously described [8,9].
2.2. Northern blot analysis
A single-step method of isolating RNA using acid guanidinium
thiocyanate-phenol-chloroform extraction as described by Chomczyn-
ski and Sacchi [10] was used to isolate total cellular RNA from cells
grown in 75 cm2 tissue culture £asks. Twenty micrograms of total
RNA per lane were electrophoresed on formaldehyde-agarose gels,
blotted onto nylon membranes, and baked in an oven for 2 h at
80‡C. For hybridization with the cDNA probe, which was the nested
PCR product described below, the blots were prehybridized in
5USSPE (0.75 M NaCl, 0.05 M NaH2PO4, 0.005 M EDTA),
10UDenhardt’s solution, 50% formamide, 2% sodium dodecyl sulfate
(SDS), and 100 Wg/ml of denatured salmon sperm DNA at 42‡C. The
cDNA probes were labeled with [K-32P]dCTP using Amersham’s ran-
dom primer labeling kit, and hybridization was performed under the
same conditions, using probes with s 2U106 counts min31 ml31. A
series of 20 min washes was then performed, starting with 2USSC (0.3
M NaCl and 0.03 M sodium citrate) at room temperature, followed
by 0.5USSC at 42‡C, 0.2USSC at 42‡C, and if necessary, 0.1USSC at
42‡C. All the wash bu¡ers contained 0.1% SDS.
2.3. RT-PCR
Total RNA was extracted from cell lysate, and cDNA was synthe-
sized using virus reverse transcriptase and random hexanucleotide
primers. CFTR transcripts were ampli¢ed by the polymerase chain
reaction (PCR) using Taq DNA polymerase and the CFTR primers
[11] (exon 9, HCF21: 5P-TTGCTGGATCCACTGGAGCAGG-3P ;
exons 12^13, HCF22: 5P-GCCATCAGTTTACAGACACAG-3P)
under standard conditions, with an annealing temperature of 55‡C.
‘Nested’ ampli¢cation was performed on the products of the ¢rst PCR
reaction under similar conditions, using primers located in exon 10
(HCF30: 5P-CTTCACTTCTAATGATGATTATGG-3) and exon 11
(HCF31: 5P-TCTTTCTCTGCAAACTTGGAGATG-3P).
2.4. Western blot analysis
Cells grown to 100% con£uence in 75 cm2 tissue culture £asks were
rinsed twice with ice-cold phosphate bu¡ered saline (PBS). The cells
were harvested with a cell scraper in ice-cold PBS and centrifuged at
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1000 rpm for 10 min at 4‡C. The pellets were lysed with 3U the pellet
volume of lysis bu¡er (50 mM Tris containing 1% (w/v) n-octyl-L-D-
thioglucopyranoside, 0.1% (w/v) sodium deoxycholate, 150 mM NaCl,
10 mM EDTA and 1 mM phenylmethylsulfonyl £uoride, pH 7.5.
After centrifugation (12 000 rpm for 10 min at 4‡C), the supernatants
were collected as lysate samples. The protein content of each fraction
was measured by the BCA method [12] and the samples were stored at
380‡C until required. All the samples were separated electrophoreti-
cally by 7.5% SDS-PAGE in non-reducing conditions (100 Wg protein/
lane) according to the method of Laemmli [13]. After electrophoresis,
the proteins were transferred to PVDF membranes (Millipore Corp.,
Japan) by applying 250 mV for 90 min. The membranes were incu-
bated with 5% non-fat dry milk in 0.1% Tween 20 in PBS at 4‡C
overnight. Then the membranes were washed in PBS containing
0.05% Tween 20 (PBS-T). Primary antibodies (0.2 mg/ml) were dis-
solved in PBS-T. The membranes were incubated for 1 h with mono-
clonal antibody against the CFTR protein C-terminal (Genzyme Inc.,
USA) (1:500 dilution in PBS-T), washed in PBS-T, and then incu-
bated for 1 h with horseradish peroxidase (HRP)-conjugated sheep
anti-mouse IgG as the secondary antibody (Jackson ImmunoResearch
Laboratories Inc., USA) (1:10 000 dilution in PBS-T). They were
washed in PBS-T again and the blots were developed in enhanced
chemiluminescence reagent (ECL kit, Amersham, UK) and visualized
on X-ray ¢lm after a 1^15 min exposure.
Calnexin was used as a loading control. Calnexin was detected by
polyclonal antibody against the calnexin protein C-terminal (Stress-
Gen Biotechnologies Corp., Canada) (1:1000 dilution in PBS-T con-
taining 5% skim milk powder). The secondary antibody was HRP-
conjugated donkey anti-rabbit IgG antibody (Jackson ImmunoRe-
search Laboratories Inc., USA).
2.5. Patch-clamp analysis
Whole-cell and single-channel currents were recorded as described
previously [14,15], using an Axopatch-1C ampli¢er (Axon Instru-
ments, USA). All the patch-clamp recordings were made at room
temperature.
For whole-cell experiments, the pipette solution contained 140 mM
CsCl, 2 mM MgCl2, 0.5 mM EGTA, 10 mM glucose, 2 mM Mg-ATP,
and 5 mM HEPES (pH 7.35 adjusted with 298 mosm kg31 CsOH).
The bath solution contained 170 mM Tris-HCl, 1 mM MgCl2, 2.5
mM CaCl2, 5 mM HEPES, and 10 mM glucose (pH 7.4, 325 mosm
kg31). For the whole-cell experiments, the patch pipettes had resist-
ances of 4^6 M6. The membrane was voltage-clamped to a holding
potential of 370 mV and stepped to levels between 3110 mV and
+110 mV at 55 mV intervals. The whole-cell currents were ¢ltered at
1 kHz, and digitized.
For single-channel experiments with cell-attached patches, the pip-
ette solution contained 150 mM N-methyl-D-glucamine chloride, 2.5
mM CaCl2, 2.5 mM MgCl2, and 10 mM HEPES. The bath solution
contained 150 mM NaCl, 2.5 mM CaCl2, 2.5 mM MgCl2, and 10 mM
HEPES (pH 7.3 adjusted with NaOH, 300 mosm kg31). For single-
channel experiments, the patch-pipettes had resistances of 10^12 M6.
The single-channel currents were ¢ltered at 1 kHz, digitized at 100 Hz,
and analyzed using pClamp software (Axon Instruments, USA).
3. Results
Initially, the NCI-H292, CFTE29o3 and CFBE41o3 (from
CF patients, homozygous for the CFTR delta F508 muta-
tion), and T84 cells (a representative cell line with high ex-
pression of the CFTR gene [16]) were characterized for the
expression of CFTR mRNA by Northern blot hybridization
(Fig. 1). T84 cells expressed CFTR mRNA that was approx-
imately 6.5 kb long, but the other cells did not. Next, the
expression of CFTR mRNA was investigated by RT-PCR
and its expression in T84 cells was con¢rmed by the presence
of the predicted 421 bp fragment spanning exons 9 to 12^13,
but the other cells did not (Fig. 2A). In the other cell lines, a
217 bp fragment spanning exons 10^11 was detected by nested
PCR (Fig. 2B). Western blotting analysis of the protein ex-
tracted with an antibody against CFTR C-terminal indicated
Fig. 1. Expression of CFTR mRNA in human epithelial cell lines.
Autoradiographic analysis of a representative Northern blotting
with 32P-labeled CFTR probe. Total cytoplasmic RNA (20 Wg/lane)
was loaded in each lane. Lane 1: NCI-H292, lane 2: T84, lane 3:
CFTE29o3, lane 4: CFBE41o3.
Fig. 2. Reverse transcriptase PCR analysis for the presence of
CFTR mRNA in human epithelial cell lines. A: The cytoplasmic
RNA was converted to ¢rst-strand cDNA and then ampli¢ed with
primers at the 5P and 3P ends of exons 9 and 12^13. The predicted
fragments of 421 bp for CFTR mRNA were present. Lane M:
DNA size marker, lane 1: NCI-H292, lane 2: T84, lane 3:
CFTE29o3, lane 4: CFBE41o3. B: The RT-PCR products were
nested-ampli¢ed with primers at the 5P and 3P ends of exons 9 and
10^11. The predicted fragments 217 bp for CFTR mRNA were
present. Lane M: DNA size marker, lane 1: NCI-H292, lane 2:
CFTE29o3, lane 3: CFBE41o3.
Fig. 3. Expression of CFTR protein in human epithelial cell lines.
Total cellular protein (100 Wg/lane) was loaded. Lane 1: NCI-H292,
lane 2: T84. Immunoreactive proteins were detected with antibody
against the CFTR protein C-terminal by enhanced chemilumines-
cence. Calnexin was used as a loading control.
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that cells produced a 170 kDa antigenic protein, comparable
to that seen in protein extracted from T84 colon carcinoma
cells (Fig. 3). This band was previously identi¢ed as CFTR
protein [17^19].
To examine the expression of CFTR function, whole-cell
Cl3 currents were tested in NCI-H292 cells. Large activated,
cAMP-dependent Cl3 currents were observed in cells (Fig.
4A^C). The reversal potential of the CPT-cAMP-stimulated
current was 30.8 þ 4.9 mV, which agreed with the theoretically
predicted value of 27.9 mV. Generally, the current-voltage (I-
V) relationship for the cAMP-stimulated whole-cell CFTR
Cl3 current was linear (Fig. 4C). The I-V relationship in
NCI-H292 cells was almost linear, although at 110 mV, an
outwardly rectifying Cl3 current appeared, as reported previ-
ously in other airway epithelial cells [20].
Cell-attached patch recording was used to identify the chan-
nels that underlie the whole-cell Cl3 conductance described
above. NCI-H292 cells possessed low-conductance channels
stimulated by 50 WM forskolin (Fig. 5A). The stimulated
channel activities were suppressed by 50 WM glibenclamide,
a CFTR channel blocker [21] (data not shown). The I-V curve
was linear and the conductance, measured as the slope con-
ductance through 0 mV, was 9.89 pS (Fig. 5B). These proper-
ties of the cAMP-stimulated Cl3 channel in NCI-H292 cells
were very similar to previously reported values for CFTR
[15,22].
4. Discussion
Our results indicate that NCI-H292 cells with a low level of
CFTR gene expression possess enough functional CFTR to
produce a physiological response. NCI-H292 cells may belong
to the second group described in a previous report [23]. This
group includes epithelial cells, including carcinoma cell lines
Fig. 4. Representative whole-cell current recordings from airway epithelial cells. A and B: Current recordings before and after the application
of 1 mM CPT-cAMP in NCI-H292 cell. C: Corresponding current-voltage relationships of the current records shown in A and B. D and E:
Current recordings before and after the application of 1 mM CPT-cAMP in CFTE29o3 cell. F: Corresponding current-voltage relationships of
the current records shown in D and E. Membrane voltage was held at 370 mV.
Fig. 5. Single channel currents in NCI-H292 cells. A and B: Single channel current recordings under cell-attached condition before and after
the application of 50 WM forskolin in NCI-H292 cell. C: Corresponding current-voltage relationships of the forskolin-induced current records.
Vp =340 mV. Data are representative of seven experiments.
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such as HeLa cervical carcinoma cells and HS-24 bronchial
carcinoma cells [23], as well as transformed cell lines such as
BET-1A bronchial cells and 293 kidney epithelial cells [23],
which have lower levels of transcription and fewer mRNA
transcripts. Interestingly, although the level of mRNA tran-
scription in NCI-H292 cells was lower than that in T84 cells,
the level of protein expression was almost the same. This level
of protein expression was supported by electrophysiological
data. At present, it is unclear whether the translation e⁄-
ciency or protein stability is lower in T84 cells than in NCI-
H292 cells, or if the CFTR translation machinery is already
saturated in NCI-H292 cells.
The CFTR protein is a well-described regulator of epithelial
ion transport and extracellular £uid composition, which acts
at the outer cell surface. Recently, CFTR was identi¢ed as the
bacterial ligand for ingestion in epithelial cell internalization
in Pseudomonas aeruginosa [24]. Therefore, cystic ¢brosis pa-
tients are susceptible to P. aeruginosa, because without CFTR
on the epithelial cell surface this clearance mechanism cannot
prevent bacterial colonization. NCI-H292 is commonly used
to study bacterial and viral infection and in£ammation in
airway epithelial cells [2^7]. We initially assumed that CFTR
function in NCI-H292 cells was low, facilitating bacterial in-
fection. However, the present results indicate that NCI-H292
cells possess normal CFTR function. In CF, the loss of CFTR
elevates the salt concentration in airway surface liquid and
sweat by related mechanisms; the elevated NaCl concentra-
tion is due to a block in transcellular Cl3 movement. A high
NaCl concentration may predispose CF airways to bacterial
infection by inhibiting endogenous antibacterial defenses. Spe-
ci¢c anti-bacterial proteins like L-defensins and lysozyme are
inhibited at high NaCl concentrations [25]. Although we did
not examine the expression of L-defensins and lysozyme in
NCI-H292 cells, it is possible that NCI-H292 cells may ex-
press L-defensins and lysozyme at low levels.
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